|
Market Closed -
OTC Markets
20:32:11 11/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 18.50 USD | +14.20% |
|
-.--% | - |
| 10-27 | Exosens (-7%) hit by slumping profitability, analysts remain confident | |
| 10-27 | Exosens Q3 revenue rises 23.5% on stronger demand, capacity ramp-up | RE |
Company Valuation: Exosens
Data adjusted to current consolidation scope
| Fiscal Period: December | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Market Cap 1 | 986.7 | 2,459 | 2,897 | - | - |
| Change | - | 149.26% | 17.78% | - | - |
| Enterprise Value (EV) 1 | 1,131 | 2,657 | 3,056 | 2,988 | 2,905 |
| Change | - | 134.98% | 15.03% | -2.25% | -2.76% |
| P/E | 31.9x | 57.7x | 33.8x | 24.5x | 21x |
| PBR | 2.39x | 5.51x | 5.66x | 4.77x | 4.06x |
| PEG | 0x | 1.5x | 0x | 0.6x | 1.3x |
| Capitalization / Revenue | 2.5x | 5.25x | 5.12x | 4.51x | 4.02x |
| EV / Revenue | 2.87x | 5.68x | 5.41x | 4.65x | 4.03x |
| EV / EBITDA | 9.54x | 17.5x | 16.4x | 13.9x | 11.8x |
| EV / EBIT | 11.9x | 20.8x | 19.1x | 16.2x | 13.7x |
| EV / FCF | 20.4x | 46.4x | 49.5x | 35.1x | 26.3x |
| FCF Yield | 4.9% | 2.16% | 2.02% | 2.85% | 3.81% |
| Dividend per Share 2 | 0.1 | 0.3 | 0.3582 | 0.5237 | 0.6346 |
| Rate of return | 0.51% | 0.62% | 0.63% | 0.92% | 1.12% |
| EPS 2 | 0.61 | 0.84 | 1.684 | 2.325 | 2.704 |
| Distribution rate | 16.4% | 35.7% | 21.3% | 22.5% | 23.5% |
| Net sales 1 | 394.1 | 468.2 | 565.4 | 642.2 | 721 |
| EBITDA 1 | 118.5 | 151.6 | 185.9 | 214.6 | 245.5 |
| EBIT 1 | 95.3 | 127.6 | 159.7 | 184.1 | 211.7 |
| Net income 1 | 30.7 | 42.7 | 78.47 | 114.5 | 134.6 |
| Net Debt 1 | 144.1 | 197.7 | 159.6 | 91 | 8.443 |
| Reference price 2 | 19.43 | 48.45 | 56.90 | 56.90 | 56.90 |
| Nbr of stocks (in thousands) | 50,783 | 50,762 | 50,911 | - | - |
| Announcement Date | 03/03/25 | 23/02/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 34.47x | 6.31x | 26.15x | 0.6% | 312B | ||
| 31.37x | 3.04x | 17.55x | 1.42% | 270B | ||
| 26.08x | 1.72x | 12.79x | 1.75% | 170B | ||
| 20.8x | 1.97x | 14.29x | 2.2% | 147B | ||
| 28.93x | 4.19x | 17.53x | 1.18% | 137B | ||
| -125.25x | 1.64x | 43.48x | -.--% | 136B | ||
| 27.66x | 3.01x | 13.65x | 1.49% | 128B | ||
| 21.44x | 1.82x | 14.96x | 1.7% | 101B | ||
| 35.36x | 8.05x | 24.87x | 0.27% | 79.22B | ||
| Average | 11.21x | 3.53x | 20.59x | 1.18% | 164.26B | |
| Weighted average by Cap. | 14.95x | 3.63x | 20.76x | 1.17% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- EXENS Stock
- EXSNY Stock
- Valuation Exosens
Select your edition
All financial news and data tailored to specific country editions
















